What New Prior Authorization Metrics Mean for Clinical Labs
KFF looks into payer claims denials, which continue to be scrutinized
Already a member? Log in here
Legislation-lir
Subscribe today for access to
Articles and Reports
New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
Trump Budget “Blueprint”: 4 Ways It Will Impact Labs
...
Already a member? Log in here
New Laws: Civil Monetary Penalties Get More Expensive—and Easier to Dish Out
...
Already a member? Log in here
So, Now What? How a Trump Presidency Will Impact Labs & the ACA
...
Already a member? Log in here
Labs Want Congress to Intervene on LDT Regulation
...
Already a member? Log in here
Bill Would Strip California of Its Authority to Regulate Laboratories
...
Already a member? Log in here
ACLA Uses Cancer Initiative to Lobby on PAMA, LDTs
...
Already a member? Log in here
Despite Big Write-offs, Quest & LabCorp Report Strong First Quarters
...
Already a member? Log in here
OIG Recommends Medicare Payment Cuts
...
Already a member? Log in here
- « Previous
- 1
- 2
- 3
- 4
- Next »